Skip to content
Combined Shape Created with Sketch.
  • COVID-19
  • EyewireTV
  • Stocks
  • Interests
    • Cataract and Refractive Eye-Grey Created with Sketch.
    • Glaucoma Gauge-Grey Created with Sketch.
    • Healthcare Cross-Grey Created with Sketch.
    • Optometry Laser-Grey Created with Sketch.
    • Product Approvals Gear-Grey Created with Sketch.
    • Retina Laser-Grey Created with Sketch.
  • More
    • Events
    • Subscribe
    • About
    • Send a Tip
    • Advertising
    • Privacy Policy
  • COVID-19
  • EyewireTV
  • Stocks
  • Interests
    • Cataract and Refractive Eye-Grey Created with Sketch.
    • Glaucoma Gauge-Grey Created with Sketch.
    • Healthcare Cross-Grey Created with Sketch.
    • Optometry Laser-Grey Created with Sketch.
    • Product Approvals Gear-Grey Created with Sketch.
    • Retina Laser-Grey Created with Sketch.
  • Events
  • About
  • Send a Tip
  • Advertising
  • Privacy Policy

Dry Eye

12.01.20

Alcon Canada to Launch a Professional Line of Systane Ultra Hydration Lubricant Eye Drops Preservative Free

Source: Alcon

11.24.20

Report: Dry Eye Treatment Devices Market Size Worth $400.8 Million By 2027

Source: Grand View Research, Inc.

11.16.20

New Research Reveals Critical Role of Ophthalmologists in Maintaining Ongoing Dry Eye Disease Care During COVID-19

Source: Santen

11.16.20

Kala Pharmaceuticals Provides Update on Launch Plans for Eysuvis for the Treatment of Dry Eye Disease

Source: Kala Pharmaceuticals

11.13.20

Oyster Point Pharma Announces Clinical Data Presentations on OC-01 Nasal Spray for Dry Eye Disease at AAO Virtual

Source: Oyster Point Pharma

11.10.20

I-MED Pharma Launches Tearcheck Dry Eye Analysis in Canada

Source: I-MED Pharma

10.27.20

Kala Pharmaceuticals Receives FDA Approval of Dry Eye Disease Treatment Eysuvis

Source: Kala Pharmaceuticals

10.01.20

New Company TearRestore Launches Reusable Heat Packs to Target the Meibomian Glands

Source: TearRestore

09.29.20

Aerie Pharmaceuticals Announces Acceptance of Its Investigational New Drug Application for AR-15512 Eye Drop for Dry Eye Disease

Source: Aerie Pharmaceuticals

09.28.20

Aurinia Completes Final Patient Treatment in AUDREY Phase 2/3 Clinical Trial of Voclosporin Ophthalmic Solution for Dry Eye

Source: Aurinia Pharmaceuticals

View more stories

Home

Menu

Share

  • Cataract and Refractive
  • Cornea
  • Glaucoma
  • Healthcare
  • Innovation
  • Optometry
  • Product Approvals
  • Retina
  • Events
  • About
  • Send a Tip
  • Advertising
  • Contact
  • EyewireTV
  • Stocks
  • Privacy Policy
Created with Sketch. Created with Sketch. Created with Sketch. Created with Sketch.
eyewire-news-color bmc-mark Created with Sketch.

© 2021 Bryn Mawr Communications, LLC.

All Rights Reserved.